Table 4.

Participation and outcome rates in BCH and European screening programs.

BCH programEU programsEU guidelines Desirable level
Participation and outcome rates% (95 CI)% (95 CI)%
Participation rates, all92.8 (92.20–93.40)>65%
 Women92.49 (91.73–93.21)
 Men93.71 (92.48–94.79)
Positive test rate, all12.5 (11.70–13.30)6.94 (6.91–6.96)
 Women12.46 (11.65–13.30)5.67 (5.64–5.70)
 Men13.54 (11.93–15.28)8.48 (8.44–8.52)
Follow-up colonoscopy compliance rate, all84.6 (81.87–87.06)74.44 (74.24–74.64)>95
 Women84.27 (80.96–87.20)77.5 (77.21–77.79)
 Men85.40 (80.11–89.73)74.38 (74.10–74.65)
Wait time for colonoscopy <31 days, all47.6 (43.73–51.49)>95
Follow-up colonoscopy completion rate, all99.1 (98.04–99.67)94.5 (94.38–94.62)>95
 Women99.57 (98.46–99.95)93.96 (93.79–94.13)
 Men98.44 (95.50–99.68)95.60 (95.45–95.75)
Adenoma detection rate, all64.2‰ (58.2–70.6)37.90‰ (37.7–38.10)
 Women61.30‰ (54.50–68.70)24.50‰ (24.30–24.70)
 Men72.00‰ (59.90–85.50)54.00‰ (53.60–54.30)
Advanced adenoma detection rate, all17.7‰ (14.6–21.3)14.0‰ (13.90–14.10)
 Women17.00‰ (13.50–21.30)8.80‰ (8.70–8.90)
 Men19.50‰ (13.40–27.40)20.30‰ (20.00–20.50)
Cancer detection rate, all6.0‰ (4.20–8.30)2.30‰ (2.30–2.40)
 Women4.90‰ (3.10–7.40)1.90‰ (1.80–1.90)
 Men9.20‰ (5.10–15.10)2.80 (2.80–2.90)
PPV adenoma, all59.94 (56.08–63.70)72.92 (72.70–73.13)
 Women60.75 (56.10–65.25)58.19 (57.83–58.54)
 Men61.14 (53.88–68.06)84.66 (84.42–84.89)
PPV advanced adenoma, all16.54 (13.78–19.60)26.96 (26.75–27.17)
 Women16.89 (13.56–20.65)20.89 (20.59–21.18)
 Men16.58 (11.63–22.59)31.80 (31.50–32.10)
PPV cancer, all5.61 (3.98–7.66)4.46 (4.36–4.56)
 Women4.82 (3.05–7.21)4.45 (4.30–4.60)
 Men7.77 (4.41–12.49)4.45 (4.32–4.59)